WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 28-May-2015 (Data received as of 22-May-2015)
Next overall update July 2015
2014 data are provisional
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 1'9001 Infant (under 12 months) mortality rate: 342
GDP / capita (US$): 5'1671 Child (under 5 years) mortality rate: 402

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 29'325  28'934  28'541  28'152  27'769  24'829  20'555  16'027 
Births 620  622  623  623  621  578  704  576 
Surviving infants 593  595  595  595  593  548  660  533 
Pop. less than 5 years 2'954  2'977  2'989  2'962  2'874  2'881  3'254  2'491 
Pop. less than 15 years 8'299  8'277  8'274  8'275  8'267  9'258  8'436  6'595 
Female 15-49 years 8'211  8'127  8'034  7'935  7'836  6'455  4'787  3'661 

Number of reported case

(Click for retrospective incidence data for Uzbekistan)
Diphtheria 12 
Japanese encephalitis
Measles 476  117  80  3'943 
Mumps 2'336  3'256  2'300  1'160  1'418  3'949 
Pertussis 69  42  62  36  33  77  713 
Polio*
Rubella 23  454 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)**
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Uzbekistan)
Vaccine year result method % card seen                                                
BCG 2005  100  MICS   96  99*  99*  99*  99*  99  98 
DTP1 2005  99  MICS   96  99*  99*  99*  99  99  97 
DTP3 2005  93  MICS   96  99*  99  99  99  99  99 
HepB_BD          99*  99*  99*  99*  48 
HepB3 2005  90  MICS   96  99*  99  99  99  99 
Hib3          99*  99  99  99  99 
JapEnc         
MCV          99*  97  99*  99*  98  99 
MCV2          99*  99*  99*  99*  99 
PCV1         
PCV3         
Pol3 2005  90  MICS   96  99*  99  99*  99*  99  99 
Rota1          99* 
Rota_last          99* 
Rubella1          99*  97  99*  99* 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Uzbekistan)
BCG 99  99  99  99  98 
DTP1 99  99  99  99  99 
DTP3 99  99  99  99  99 
HepB3 99  99  99  99 
HepB_BD 99  99  99  48 
Hib3 99  99  99  99 
MCV 97  99  99  98  99 
MCV2 99  99  99  54  98 
PCV3
Pol3 99  99  99  99  99 
Rota_last

Number of districts in the country 196  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 3 days; Yes
DTwP 16 months; Yes
DTwPHibHepB 2, 3, 4 months; Yes
HepB Birth; Yes
MMR 1, 6 years; Yes
OPV 3 days; 2, 3, 4, 16 months; 7 years; Yes
Rotavirus 2, 3 months; Yes
Td 7, 16 years;

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2015-2018  2010-2015  2010-2015  2010-2015  2010-2015  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 196  195  194  195    199   

System performance

Total Nº districts in country number 196  195  196  195  199  199  199 
Nº districts with DTP3 coverage >=80% number 196  195  196  199  199  199 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 196  195  196    199  147  142 
% of districts with MCV1 coverage >=95% From 0 to 100% 100  100  100    100  74  71 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 80  72      11   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes         

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.